AnaptysBio Inc (ANAB.OQ)
ANAB.OQ on NASDAQ Stock Exchange Global Select Market
54.90USD
25 Jun 2019
54.90USD
25 Jun 2019
Change (% chg)
$1.09 (+2.03%)
$1.09 (+2.03%)
Prev Close
$53.81
$53.81
Open
$53.94
$53.94
Day's High
$56.13
$56.13
Day's Low
$52.93
$52.93
Volume
129,564
129,564
Avg. Vol
97,165
97,165
52-wk High
$110.00
$110.00
52-wk Low
$52.93
$52.93
About
AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro,... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $1,454.15 |
| Shares Outstanding(Mil.): | 27.02 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ANAB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 105.08 | 37.43 |
| EPS (TTM): | -2.68 | -- | -- |
| ROI: | -17.83 | 7.78 | 12.14 |
| ROE: | -18.00 | 8.33 | 17.05 |
Estimates